Robert Desantis Sells 188 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Robert Desantis also recently made the following trade(s):

• On Friday, October 25th, Robert Desantis sold 1,012 shares of Intuitive Surgical stock. The stock was sold at an average price of $514.00, for a total transaction of $520,168.00.
• On Tuesday, September 10th, Robert Desantis sold 238 shares of Intuitive Surgical stock. The stock was sold at an average price of $477.50, for a total transaction of $113,645.00.
• On Thursday, August 29th, Robert Desantis sold 188 shares of Intuitive Surgical stock. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48.
• On Monday, August 26th, Robert Desantis sold 396 shares of Intuitive Surgical stock. The stock was sold at an average price of $486.88, for a total value of $192,804.48.
• On Monday, August 12th, Robert Desantis sold 240 shares of Intuitive Surgical stock. The shares were sold at an average price of $464.76, for a total value of $111,542.40.

Intuitive Surgical Trading Up 1.1 %

Intuitive Surgical stock traded up $5.43 during trading on Tuesday, hitting $516.31. 1,064,808 shares of the company were exchanged, compared to its average volume of 1,464,542. The company has a market capitalization of $183.90 billion, a P/E ratio of 82.14, a PEG ratio of 5.11 and a beta of 1.39. The business’s 50 day moving average is $488.56 and its 200 day moving average is $443.89. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $523.34.

Institutional Trading of Intuitive Surgical

Institutional investors have recently made changes to their positions in the company. Aviance Capital Partners LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $612,000. Miracle Mile Advisors LLC increased its position in shares of Intuitive Surgical by 2.8% during the first quarter. Miracle Mile Advisors LLC now owns 1,478 shares of the medical equipment provider’s stock valued at $590,000 after acquiring an additional 40 shares during the last quarter. Claro Advisors LLC lifted its holdings in Intuitive Surgical by 25.0% during the first quarter. Claro Advisors LLC now owns 819 shares of the medical equipment provider’s stock worth $327,000 after acquiring an additional 164 shares during the period. Vaughan Nelson Investment Management L.P. boosted its position in Intuitive Surgical by 33.5% in the first quarter. Vaughan Nelson Investment Management L.P. now owns 4,260 shares of the medical equipment provider’s stock worth $1,700,000 after purchasing an additional 1,070 shares during the last quarter. Finally, Cullinan Associates Inc. grew its stake in Intuitive Surgical by 300.0% in the 1st quarter. Cullinan Associates Inc. now owns 6,400 shares of the medical equipment provider’s stock valued at $2,554,000 after purchasing an additional 4,800 shares during the period. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of several recent analyst reports. Robert W. Baird boosted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Barclays increased their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Morgan Stanley increased their price objective on shares of Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research report on Monday, July 15th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.